CAS 1791396-46-7

Masupirdine mesylate

CAS: 1791396-46-7

Masupirdine mesylate

Reinheit: ≥98%

Molekulargewicht: 670.61g/mol

Ref: 54-BUP04296

SUVN-502 dimesylate

CAS: 1791396-46-7

SUVN-502 dimesylate is a pharmaceutical combination that contains the acetylcholinesterase inhibitor donepezil and the 5-HT6 receptor antagonist pruvincamine. It is used for the treatment of dementia symptoms, with an effective dose of 40 mg/day. SUVN-502 dimesylate has a dual mechanism of action by inhibiting acetylcholinesterase and antagonizing 5-HT6 receptors. The 5-HT6 receptor is involved in memory consolidation and learning, as well as cognition. This drug may be useful in treating people who have moderate to severe dementia, particularly if they are already taking donepezil or other acetylcholinesterase inhibitors.

Formel: C₂₃H₃₂BrN₃O₉S₃

Reinheit: Min. 95%

Molekulargewicht: 670.6 g/mol

Ref: 3D-RWC39646

Masupirdine mesylate

CAS: 1791396-46-7

Masupirdine mesylate (SUVN-502 mesylate) is a 5-HT6 receptor antagonist.Masupirdine mesylate is used to study neurological disorders such as Alzheimer's disease

Formel: C₂₃H₃₂BrN₃O₉S₃

Reinheit: 99.57%

Farbe und Form: Solid

Molekulargewicht: 670.61

Ref: TM-T11949